Cargando…
Interleukin‐37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction
Excessive osteoclast formation is one of the important pathological features of inflammatory bone destruction. Interleukin‐37 (IL‐37) is an anti‐inflammatory agent that is present throughout the body, but it displays low physiological retention. In our study, high levels of the IL‐37 protein were de...
Autores principales: | Tang, Ruohui, Yi, Jin, Yang, Jing, Chen, Yueqi, Luo, Wei, Dong, Shiwu, Fei, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587950/ https://www.ncbi.nlm.nih.gov/pubmed/30414292 http://dx.doi.org/10.1002/jcp.27526 |
Ejemplares similares
-
Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis
por: Chen, Yueqi, et al.
Publicado: (2020) -
Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB–NFATc1 signal pathway
por: Yang, Jing, et al.
Publicado: (2019) -
Streptolysin O derived from Streptococcus pyogenes inhibits RANKL-induced osteoclastogenesis through the NF-κB signaling pathway
por: Yi, Jin, et al.
Publicado: (2019) -
The role of dendritic cells derived osteoclasts in bone destruction diseases
por: Wang, Bo, et al.
Publicado: (2020) -
Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation
por: Dou, Ce, et al.
Publicado: (2016)